Amanote Research
Register
Sign In
An Open, Multi-Centre, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Paclitaxel, UFT, and Leucovorin in Patients With Advanced Gastric Cancer
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6603225
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 27, 2006
Authors
Y Chao
C P Li
T Y Chao
W C Su
R K Hsieh
M F Wu
K H Yeh
W Y Kao
L T Chen
A L Cheng
Publisher
Springer Science and Business Media LLC
Related search
Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Docetaxel Versus Paclitaxel Combined With 5-Fu and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Cancer Research and Treatment
Cancer Research
Oncology
A Retrospective Study of the Safety and Efficacy of Paclitaxel Plus Ramucirumab in Patients With Advanced or Recurrent Gastric Cancer With Ascites
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase II Trial of Haptaplatin/5-Fu and Leucovorin for Advanced Stomach Cancer
Cancer Research and Treatment
Cancer Research
Oncology
A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Comparative Analysis of the Efficacy and Safety of Chemotherapy With Oxaliplatin Plus Fluorouracil/Leucovorin Between Elderly Patients Over 65 Years and Younger Patients With Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase I Clinical Trial of Hepatic Arterial Infusion of Paclitaxel in Patients With Advanced Cancer and Dominant Liver Involvement
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Pharmacogenetic Clinical Randomised Phase II Trial to Evaluate the Efficacy and Safety of FOLFIRI With High-Dose Irinotecan (HD-FOLFIRI) in Metastatic Colorectal Cancer Patients According to Their UGT1A 1 Genotype
British Journal of Cancer
Cancer Research
Oncology
